A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
| Autor: | Pant, S. *, Saleh, M., Bendell, J., Infante, J.R., Jones, S., Kurkjian, C.D., Moore, K.M., Kazakin, J., Abbadessa, G., Wang, Y., Chen, Y., Schwartz, B., Camacho, L.H. |
|---|---|
| Zdroj: | In Annals of Oncology July 2014 25(7):1416-1421 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|